Business Description
Steris PLC
NAICS : 339113
SIC : 5047
ISIN : BRS1TEBDR005
Share Class Description:
BSP:S1TE34: BRDRDescription
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.07 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.36 | |||||
| Debt-to-EBITDA | 1.72 | |||||
| Interest Coverage | 7.36 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.62 | |||||
| Beneish M-Score | -2.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.7 | |||||
| 3-Year EBITDA Growth Rate | 16.4 | |||||
| 3-Year EPS without NRI Growth Rate | 21.2 | |||||
| 3-Year FCF Growth Rate | 5.6 | |||||
| 3-Year Book Growth Rate | 11.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 9.34 | |||||
| Future 3-5Y Total Revenue Growth Rate | 6.49 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 98.55 | |||||
| 14-Day RSI | 93.89 | |||||
| 6-1 Month Momentum % | 13.59 | |||||
| 12-1 Month Momentum % | 31.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.41 | |||||
| Quick Ratio | 1.55 | |||||
| Cash Ratio | 0.21 | |||||
| Days Inventory | 93.54 | |||||
| Days Sales Outstanding | 67.42 | |||||
| Days Payable | 32.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Payout Ratio | 0.18 | |||||
| 3-Year Dividend Growth Rate | 8.9 | |||||
| 3-Year Average Share Buyback Ratio | -5 | |||||
| Shareholder Yield % | 3.43 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.01 | |||||
| Operating Margin % | 17.99 | |||||
| Net Margin % | 8.49 | |||||
| FCF Margin % | 13.27 | |||||
| ROE % | 6.83 | |||||
| ROA % | 4.02 | |||||
| ROIC % | 7.08 | |||||
| ROC (Joel Greenblatt) % | 27.21 | |||||
| ROCE % | 8.94 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 47.49 | |||||
| Forward PE Ratio | 23.36 | |||||
| PE Ratio without NRI | 23.34 | |||||
| Shiller PE Ratio | 57.28 | |||||
| Price-to-Owner-Earnings | 37.26 | |||||
| PEG Ratio | 1.63 | |||||
| PS Ratio | 4.04 | |||||
| PB Ratio | 3.11 | |||||
| Price-to-Tangible-Book | 46.72 | |||||
| Price-to-Free-Cash-Flow | 30.39 | |||||
| Price-to-Operating-Cash-Flow | 18.78 | |||||
| EV-to-EBIT | 25.57 | |||||
| EV-to-Forward-EBIT | 26.56 | |||||
| EV-to-EBITDA | 16.34 | |||||
| EV-to-Forward-EBITDA | 16.01 | |||||
| EV-to-Revenue | 4.45 | |||||
| EV-to-Forward-Revenue | 4.29 | |||||
| EV-to-FCF | 33.41 | |||||
| Price-to-Projected-FCF | 2.02 | |||||
| Price-to-DCF (Earnings Based) | 1.42 | |||||
| Price-to-DCF (FCF Based) | 2.3 | |||||
| Price-to-Median-PS-Value | 0.96 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.45 | |||||
| Price-to-Graham-Number | 6.97 | |||||
| Earnings Yield (Greenblatt) % | 3.92 | |||||
| FCF Yield % | 3.31 | |||||
| Forward Rate of Return (Yacktman) % | 18.51 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Steris PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil R$) | 26,647.38 | ||
| EPS (TTM) (R$) | 1.157 | ||
| Beta | -0.16 | ||
| Volatility % | 13.96 | ||
| 14-Day RSI | 93.89 | ||
| 14-Day ATR (R$) | 0.0007 | ||
| 20-Day SMA (R$) | 67.27 | ||
| 12-1 Month Momentum % | 31.9 | ||
| 52-Week Range (R$) | 51 - 67.27 | ||
| Shares Outstanding (Mil) | 1,974.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Steris PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Steris PLC Stock Events
| Event | Date | Price(R$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Steris PLC Frequently Asked Questions
What is Steris PLC(BSP:S1TE34)'s stock price today?
The current price of BSP:S1TE34 is R$67.27. The 52 week high of BSP:S1TE34 is R$67.27 and 52 week low is R$51.00.
When is next earnings date of Steris PLC(BSP:S1TE34)?
The next earnings date of Steris PLC(BSP:S1TE34) is 2025-02-07 Est..
Does Steris PLC(BSP:S1TE34) pay dividends? If so, how much?
Steris PLC(BSP:S1TE34) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers